New MRI method could spare diabetics from painful kidney biopsies

NCT ID NCT06452862

Recruiting now Knowledge-focused Sponsor: Shengjing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether advanced MRI scans can noninvasively diagnose and track diabetic kidney disease (DKD). Researchers will scan 150 people—including DKD patients and healthy volunteers—using multiple MRI techniques. The goal is to see if these scans can predict kidney function decline and reduce the need for invasive biopsies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic Resonance Imaging (MRI)
What this could lead to: If successful, this could provide a noninvasive way to diagnose and monitor diabetic kidney disease, potentially reducing the need for kidney biopsies.
What could go wrong: This is an early-stage observational study, not a treatment trial. The MRI techniques may not prove accurate enough to replace current methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC KIDNEY DISEASE

Contacts and locations

Locations

Shengjing Hospital
RECRUITING

Shenyang, Liaoning, 110004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.